is a drug discovery company. The company has attracted over $4 million in commercial STTR/SBIR grants, which recently enabled a breakthrough in its approach to treatment of strains of drug-resistant bacteria. has obtained pre-seed funding with TechGROWTH Ohio to progress this breakthrough to preclinical drug safety studies.